{
    "title": "GlaxoSmithKline's consumer arm could be thrust into a full-blown bidding war after rejecting three offers from Unilever at the end of last year",
    "url": "https://www.dailymail.co.uk/money/markets/article-10408449/After-Unilever-makes-shock-offer-rival-bidders-circling-GSK-consumer-arm.html",
    "date": "2022-01-16",
    "keywords": [
        "business",
        "consumer",
        "unilever",
        "gsk",
        "cent",
        "arm",
        "bidding",
        "war",
        "healthcare",
        "equity",
        "share",
        "investment",
        "fund",
        "year",
        "walmsley",
        "monteyne",
        "boss",
        "money",
        "diy",
        "platform",
        "investor",
        "capital",
        "account",
        "fee",
        "end",
        "offer",
        "toothpaste",
        "analyst",
        "purchase",
        "idea",
        "price",
        "proposal",
        "value",
        "megadeal",
        "cure",
        "glaxosmithkline",
        "dave",
        "article",
        "trading",
        "monday",
        "head",
        "deal",
        "cardsunilever",
        "bid",
        "order",
        "counter",
        "chief",
        "executive",
        "emma",
        "london",
        "stakebut",
        "pressure",
        "elliott",
        "management",
        "process",
        "unit",
        "cvc",
        "running",
        "health",
        "ben",
        "jerrys",
        "ice",
        "cream",
        "soap",
        "growth",
        "isnt",
        "plus",
        "core",
        "risk",
        "isa",
        "trade",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "commission",
        "editorial",
        "independence",
        "investing"
    ],
    "category": [
        "money",
        "markets"
    ]
}